InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...
Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...
Holiday mail will cost more this year as stamp prices rise again. Here’s how much your cards will cost you now.
Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of Gazyva/Gazyvaro over standard ...
Chalkbeat on MSN
Philadelphia’s tutoring program shows promise but faces familiar obstacle: expanding it effectively
Philadelphia school leaders say high-impact tutoring has boosted achievement. But only around 600 kids get it, and schools ...
A study of five waterways, including the River Lagan and Lough Neagh, finds cocaine and its by-product in 91% of almost 140 ...
Investor's Business Daily on MSN
In the 'uber bull' biotech market, is structure the next Metsera?
In a post-Metsera world, Structure Therapeutics could be the next big takeover candidate, analysts said Tuesday.
Examining the cost of outpatient care for female patients: insights from private healthcare services
Introduction The Indian healthcare system is consistently focusing on delivering equitable and affordable healthcare to its citizens. Yet, despite the country’s progress towards universal health ...
9h
BlackRock, Inc. (BLK) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript
BlackRock, Inc. ( BLK) Goldman Sachs 2025 U.S. Financial Services Conference December 9, 2025 2:20 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback